文献速递头颈部肿瘤放疗

口咽癌放疗后远期幸存者中传入性压力反射衰竭与下组颅神经病的重叠

Overlap of Afferent Baroreflex Failure and Lower Cranial Neuropathies in Long-term Oropharyngeal Cancer Survivors Postradiation Therapy: Secondary Analysis of a Prospective Registry Cohort.
PubMed 文献 · Adv Radiat Oncol · 2026-06-20

该研究为前瞻性队列的二次分析,纳入2016-2019年接受放疗的414例口咽癌幸存者。中位随访6.3年,下组颅神经病(LCNP)发生率为5.8%,传入性压力反射衰竭(ABF)表现发生率为19.6%。LCNP患者中ABF表现占39%,显著高于无LCNP者的18.3%(OR=2.93,95%CI 1.22-7.06,P=.016)。

要点

  • 口咽癌放疗后LCNP患者中约39%出现ABF相关表现。
  • LCNP患者发生ABF表现的风险约为无LCNP者的2.93倍。
  • 对LCNP患者应降低ABF专项评估的门槛。

核心结论

  • 在长期口咽癌放疗幸存者中,超过三分之一的LCNP患者存在与ABF相关的表现。
  • 对该高危亚组可能需要降低ABF专项评估的门槛。

研究设计与样本

  • 研究为单中心前瞻性队列的二次分析,纳入2016-2019年接受放疗的口咽癌幸存者414例。
  • ABF表现包括新发或加重的高血压、需干预的低血压、心律失常或晕厥。
  • LCNP定义为治疗后≥3个月电子健康记录中记录的舌咽、迷走或舌下颅神经运动性神经病体征。

主要发现

  • 414例患者中87%为男性、91%为白人,诊断时中位年龄60(54-67)岁。
  • 中位随访6.3年(四分位距5.2-7),LCNP诊断23例(5.8%)。
  • 全队列ABF表现82例(19.6%),其中波动性高血压9.2%、低血压7%、心律失常3.9%、晕厥3.9%。
  • LCNP患者中ABF表现占39%,无LCNP者中占18.3%(OR=2.93;95%CI 1.22-7.06;P=.016)。

关键数值与推荐

  • ABF表现定义:新发或加重的高血压、需干预的低血压、心律失常或晕厥。
  • LCNP定义:治疗后≥3个月记录的舌咽、迷走或舌下颅神经运动性神经病体征。
  • LCNP患者中ABF表现占39%,无LCNP者中占18.3%,OR=2.93(95%CI 1.22-7.06),P=.016。

临床怎么用

  • 在口咽癌放疗后幸存者中筛查LCNP时,应同时关注ABF相关症状。
  • 对存在LCNP的患者,可考虑降低ABF专项评估的门槛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Afferent baroreflex failure (ABF) is an underrecognized late complication of radiation therapy (RT) in oropharyngeal cancer (OPC) survivors. Patients with ABF present with labile blood pressure, palpitations, lightheadedness, and syncope. ABF is attributed to fibrotic injury of the carotid sinus nerve and shares pathophysiology with lower cranial neuropathies (LCNP), which are routinely screened as part of head and neck physical examination in OPC survivorship. We evaluated the prevalence of ABF in patients with LCNPs and prior history of OPC treated with RT. METHODS AND MATERIALS: This is a secondary analysis of a prospective cohort of OPC survivors treated with RT at a tertiary cancer center (2016-2019). ABF manifestations included new or worsening hypertension, hypotension requiring intervention, arrhythmias, or syncope. LCNP was defined as motor signs of neuropathy of the glossopharyngeal, vagus, or hypoglossal cranial nerves ≥3 months after therapy documented in the electronic health record. RESULTS: Among 414 patients, 87% were men and 91% white with a median age of 60 (54-67) years at cancer diagnosis. During a median follow-up of 6.3 years (Interquartile range, 5.2-7), LCNP was diagnosed in 23 patients (5.8%). ABF manifestations were reported in 82 patients (19.6%) in the whole cohort (labile hypertension in 9.2%, hypotension in 7%, arrhythmias in 3.9%, syncope in 3.9%). ABF manifestations were present among 39% of patients with LCNP compared with 18.3% without LCNP (OR = 2.93; 95% CI, 1.22-7.06; P = .016). CONCLUSIONS: In this cohort of long-term OPC survivors treated with RT, over one-third of patients with LCNP had manifestations linked to ABF. A low threshold for dedicated ABF evaluation may be warranted in this high-risk subgroup.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Triantafyllou E, Jang I, Sahli AJ, et al. Overlap of Afferent Baroreflex Failure and Lower Cranial Neuropathies in Long-term Oropharyngeal Cancer Survivors Postradiation Therapy: Secondary Analysis of a Prospective Registry Cohort. Adv Radiat Oncol. 2026. PMID: 42502577. doi:10.1016/j.adro.2026.102121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。